Stephanie Scanlan learned about the shortages of basic chemotherapy drugs this spring in the most frightening way. Two of the three drugs typically used to treat her rare bone cancer were too scarce. She would have to go forward without them.
AHCA Secretary Jason Weida told a state House panel he is 'cautiously optimistic' the FDA will approve the plan, which the state has been pursuing since 2019.
Former drug company executive Martin Shkreli on Thursday urged a U.S. appeals court to strike down an order permanently banning him from the pharmaceutical industry.
Medicare enrollees next year could save on dozens of medications under a federal law that penalizes pharmaceutical companies if they raise prices faster than the rate of inflation.